Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Adding a second method to PROTACs could improve cancer treatment.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Juniperus plants contain compounds with potential for developing various medical treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Herbal medicine may help treat breast cancer and improve quality of life.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.